MedTrace Logo

Iron Absorption and Variations of Iron Status, Hepcidin, Inflammation and Sex Hormones During the Menstrual Cycle

NCT05580783 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-11-22

No results posted yet for this study

Summary

Iron supplementation is the first line of treatment of iron deficiency in most women, but we do not know when the best time is to supplement in the context of the menstrual cycle. With this study, we aim to measure and compare iron status, hepcidin, inflammatory markers, hormones estrogen and progesterone and changes in iron absorption at various points throughout the menstrual cycle, with a long-term view to determine best time for iron supplementation in relation to the menstrual cycle.

Conditions

  • Iron-deficiency

Interventions

OTHER

Test meal labelled with 54Fe

Each participant will receive 2 test meals containing 4mg each of isotopic tracer 54Fe

OTHER

Test meal labelled with 57Fe

Each participant will receive 2 test meals containing 4mg each of isotopic tracer 57Fe

OTHER

Test meal labelled with 58Fe

Each participant will receive 2 test meals containing 4mg each of isotopic tracer 58Fe

Sponsors & Collaborators

  • Wageningen University and Research

    collaborator OTHER

  • Sight and Life Foundation

    collaborator UNKNOWN

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Isabelle Herter-Aeberli

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-05
Primary Completion
2023-01-06
Completion
2023-05-15

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05580783 on ClinicalTrials.gov